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GBP, an Inhibitor of GSK-3, Is Implicated
in Xenopus Development and Oncogenesis
(Brannon and Kimelman, 1996; Brannon et al., 1997;
Fagotto et al., 1997), a dorsal-specific gene required for
the activation of the Spemann organizer (Lemaire et al.,
Cynthia Yost,*§ Gist H. Farr III,*§
Sarah B. Pierce,*§‖ Denise M. Ferkey,*
Michelle Mingzi Chen,*²# and David Kimelman*³
1995; Carnac et al., 1996; Fan and Sokol, 1997) and the*Department of Biochemistry
subsequent development of the embryonic axes.University of Washington
A key member of the Wnt intracellular pathway isSeattle, Washington 98195-7350
GSK-3, a negative regulator of b-catenin (Peifer et al.,²Fred Hutchinson Cancer Center
1994b; Siegfried et al., 1994) that can phosphorylate it1100 Fairview Avenue North
at an amino-terminal site (Yost et al., 1996). MutationsSeattle, Washington 98109-1024
in the serine and threonine residues at this site prevent
the ubiquination and degradation of b-catenin in Xeno-
pus (Yost et al., 1996; Aberle et al., 1997), indicating thatSummary
phosphorylation of b-catenin by GSK-3 targets it for
degradation. The phosphorylation of b-catenin by GSK-3Dorsal accumulation of b-catenin in early Xenopus
is strongly promoted by axin (Zeng et al., 1997; Ikedaembryos is required for body axis formation. Recent
et al., 1998), which binds both GSK-3 and b-cateninevidence indicates that b-catenin is dorsally stabilized
(Ikeda et al., 1998; Sakana et al., 1998). GSK-3 alsoby the localized inhibition of the kinase Xgsk-3, utilizing
phosphorylates APC, the tumor supressor protein re-a novel Wnt ligand-independent mechanism. Using a
quired for negative regulation of b-catenin in colon can-two-hybrid screen, we identified GBP, a maternal
cer cells (Munemitsu et al., 1995; Rubinfeld et al., 1996).Xgsk-3±binding protein that is homologous to a T cell
However, the role of APC in Xenopus axis formation isprotooncogene in three well-conserved domains. GBP
not clear (Vleminckx et al., 1997).inhibits in vivo phosphorylation by Xgsk-3, and ectopic
The importance of GSK-3 in Xenopus developmentGBP expression induces an axis by stabilizing b-cat-
has been shown with a dominant-negative mutant,enin within Xenopus embryos. Importantly, antisense
which stabilizes b-catenin and induces an ectopic axisoligonucleotide depletion of the maternal GBP mRNA
(Dominguez et al., 1995; He et al., 1995; Pierce anddemonstrates that GBP is required for the establish-
Kimelman, 1995; Yost et al., 1996). The same effects arement of the dorsal-ventral axis in Xenopus embryos.
seen with lithium (Kao et al., 1986; Hedgepeth et al.,Our results define a family of GSK-3±binding proteins
1997; Larabell et al., 1997), a noncompetitive inhibitorwith roles in development and cell proliferation.
of GSK-3 (Klein and Melton, 1996; Stambolic et al.,1996).
These results have led to the proposal that localized
inhibition of GSK-3 on the future dorsal side of the em-Introduction
bryo soon after fertilization leads to the localized stabili-
zation of b-catenin within the first few hours of embry-A major issue faced by all developing organisms is how
onic life (Larabell et al., 1997). How GSK-3 could beto break the symmetry of the oocyte or egg in order to
locally inhibited remains a major question. Because ec-establish the embryonic axes. In Xenopus laevis, sperm
topic expression of Wnt induces an ectopic axis (McMa-entry triggers a rotation of the cortex relative to the
hon and Moon, 1989; Smith and Harland, 1991; Sokolunderlying cytoplasm that moves an unknown determi-
et al.,1991), it ispossible that the cortical rotation movesnant from the vegetal pole to the future dorsal side of
a Wnt ligand to the future dorsal side of the embryo.the embryo, creating an asymmetry near the equator
However, no Wnt with the correct spatial distribution(Gerhart et al., 1991). Emerging evidence from a number
and axis-inducing properties has been found in Xenopusof avenues strongly supports the view that the rotation
embryos (Cui et al., 1995). Moreover, ectopic expressionactivates the Wnt pathway as a critical first step in de-
of dominant-negative mutants of Wnt or Dishevelled, atermining the future dorsal-ventral axis and, subse-
cytoplasmic protein required for Wnt signaling (Noorder-quently, the anterior-posterior axis (Moon and Kimel-
meer et al., 1994; Siegfried et al., 1994), does not blockman, 1998).
axis formation in Xenopus even though they inhibit gas-By the first cell division following fertilization, b-cate-
trula-stage Wnt signaling (Hoppler et al., 1996; Sokol,nin, a key cytoplasmic effector of the Wnt pathway (re-
1996). These results raise the possibility that the Wntviewed in Miller and Moon, 1996) accumulates on the
pathway could be activated independently of Wnt in thefuture dorsal side of the Xenopus embryo (Larabell et
early embryo, utilizing maternal factors.al., 1997). b-catenin binds the XTcf-3 transcription factor
We report here the identification of a novel maternal(Behrens et al., 1996; Huber et al., 1996; Molenaar et
Xenopus GSK-3±binding protein, GBP, which we showal., 1996) and activates the transcription of siamois
is required for the establishment of the dorsal-ventral
axis in Xenopus. We demonstrate that GBP binds GSK-3
³To whom correspondence should be addressed. in Xenopus embryos, prevents GSK-3±dependent phos-§These authors contributed equally to this work.
phorylation of an in vivo substrate, induces an ectopic‖ Present address: Department of Molecular Biology, Wellman 8,
axis, and increases b-catenin levels. Using the similarityMassachusetts General Hospital, Boston, Massachusetts 02114.
of GBP to a recently discovered T cell protooncogene# Present address: Scios Inc., 820 West Maude Ave., Sunnyvale,
California 94086. of unknown function, Frat1 (Jonkers et al., 1997), and a
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Figure 1. Expression and Binding of GBP in
Xenopus Embryos
(A) GBP and Xgsk-3 associate in vivo. Em-
bryos were injected in the animal pole at the
two-cell stage with 1.0 ng of RNA encoding
Xgsk-3-myc or GBP-FLAG, as indicated.
After 4 hr, proteins were isolated by immuno-
precipitation with or without antibodies to the
myc or FLAG epitopes, as indicated. Xgsk-3-
myc and GBP-FLAG were detected by immu-
noblotting with anti-FLAG (left side) and anti-
myc (right side) antibodies. The positions of
GBP-FLAG and Xgsk-3-myc are marked.
Each lane represents ten embryos.
(B) GBP is expressed in oocytes and em-
bryos. RNA levels were determined with the
RNase protection assay using GBP or FGF
receptor (FGFR) probes. FGFR is a ubiqui-
tously expressed gene in the Xenopus em-
bryo. UFE, unfertilized eggs; oocyte, mixture
of stages I-VI.
(C) GBP protein is present in Xenopus em-
bryos. Proteins from uninjected embryos
(lane 3) orembryos injected with 2 ng of Xgsk-
3-myc RNA in combination with 0.5 ng of
Xgsk-3FS (lane 1) or GBP (lane 2) RNA were
immunoprecipitated with anti-myc antibod-
ies 2.5 hr after injection. Samples were la-
beled with 32P as described in Experimental
Procedures, and 20% of the samples were
analyzed by SDS-PAGE. The locations of the
GBP and negative control bands analyzed in
(B) are indicated. Lane 1 represents 40 em-
bryos, and lanes 2 and 3 represent 15 em-
bryos.
(D) Eighty percent of the samples in (C) were
separated by SDS-PAGE, and protein from
the GBP bands in lanes 1, 2, and 3 and the
negative control band in lane 1 were run on
a 16% gel in the absence or presence of V8
protease.
human EST, we demonstrate that GBP contains a highly (GSK-3-myc) and GBP fused to a FLAG epitope tag
(GBP-FLAG). RNA synthesized from these constructsconserved domain required for GSK-3 binding and inhi-
bition. These studies define a family of GSK-3-binding± was injected, separately or in combination, into the ani-
mal poleof bothcells at the two-cell stage. After approxi-proteins with multiple roles in vertebrates.
mately 4 hr, the embryos were lysed and proteins were
incubated with anti-myc or anti-FLAG antibodies, andResults
the resulting immunoprecipitates were analyzed on a
Western blot. As shown in Figure 1A, GBP-FLAG wasCloning and Expression of a Novel
GSK-3±Binding Protein immunoprecipitated indirectly by Xgsk-3 almost as effi-
ciently as it was precipitated directly with the anti-FLAGTo search for a cytoplasmic regulator of Xgsk-3, we
used a modification of the yeast two-hybrid system (Hol- antibody (Figure 1A, compare lane 6 to 1 or 2). Con-
versely, Xgsk-3-myc was precipitated indirectly by GBPlenberg et al., 1995). We produced a Xenopus maternal
cDNA library by PCR and isolated 13 clones containing as efficiently as it was precipitated by the anti-myc anti-
body (Figure 1A, compare lane 14 to18 or 19). Moreover,the same insert that interacted strongly with Xgsk-3. A
full-length clone encoding a predicted protein of 169 GBP and Xgsk-3 remain associated in washes of 1 M
NaCl (data not shown), reflecting the strength of thisamino acids that we named GBP (GSK-3±binding pro-
tein) was isolated from a Xenopus oocyte library. interaction. These results demonstrate that ectopically
expressed Xgsk-3 and GBP bind each other efficientlyTo assess whether the interaction between Xgsk-3
and GBP observed in the two-hybrid screen also occurs in Xenopus embryos.
The dorsal-ventral axis in Xenopus is initiated prior toin Xenopus embryos, RNA expression constructs were
utilized that encode Xgsk-3 fused to a myc epitope tag zygotic transcription by maternal components stored in
GBP, a GSK-3 Inhibitor
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Figure 2. GBP Contains Axis-Inducing Activ-
ity and Is Blocked by Xgsk-3
(A) GBP induces ectopic axis formation in
Xenopus embryos. Two ventral or dorsal cells
were injected at the equator of 2- to 16-cell
stage embryos with 0.75 ng per blastomere
of GBP RNA, and embryos were allowed to
develop for 3 days. Representative dorsally
injected (top embryo) and ventrally injected
(bottom embryo) embryos are shown.
(B) GBP rescues axis formation in UV-irradi-
ated embryos. Fertilized eggs were UV-irradi-
ated within 40 min after fertilization. At the
2- to 4-cell stage, one cell was injected with
GBP RNA at the doses indicated. UV control
embryos were uninjected. The dorsoanterior
index (DAI) of the embryos was scored after
3 days, and the average DAI for each sample
is shown, with the sample size indicated
above. Embryos with a DAI of 0 lack dorsal
structures and those with a DAI of 5 are
normal.
(C) Xgsk-3 blocks the axis rescuing activity
of GBP. Fertilized eggs were UV-irradiated
within 40 min after fertilization. At the 2- to
4-cell stage, one cell was injected at the mar-
ginal zone with 2 ng of Xgsk-3-myc RNA or
1 ng of GBP RNA, alone or in combination,
as indicated, and the DAI was scored at 3
days. UV control embryos were uninjected.
the oocyte. To determine whether the GBP transcript is (data not shown). We conclude that endogenous GBP
protein is present in early embryos and that it binds topresent maternally, as would be predicted for a gene
that is involved in dorsal-ventral axis determination,RNA ectopically expressed Xgsk-3.
was isolated from Xenopus oocytes and early embryos
and analyzed by the RNase protection assay. Using a GBP Causes Axis Duplication and Rescues
Dorsal Axis Formation in UV-Irradiatedprobe derived from the 39 end of the GBP cDNA coding
region, we found that GBP transcripts are expressed at Xenopus Embryos
To explore the function of GBP, RNA encoding GBP wasfairly constant levels in the oocyte and early embryo
(Figure 1B). Analysis of RNA distribution by RNase pro- ectopically expressed in Xenopus embryos. Injection of
0.25 or 0.75 ng per blastomere of GBP RNA into twotection and in situ hybridization did not show any spe-
cific localization of GBP transcripts in the early embryo cells of the ventral marginal region (0.5 or 1.5 ng total)
at the 2- to 16-cell stage resulted in the development(data not shown).
In the course of our experiments, we found that when of tadpoles with split body axes, indicating duplication
of anterior dorsal structures (Figure 2A, bottom embryo).g32P-ATP was added to anti-myc immunoprecipitates
from embryos expressing ectopic Xgsk-3-myc and un- Axis duplication was typically observed in greater than
90% of the embryos injected with 1.5 ng of GBP RNAtagged GBP or GBP-FLAG, a protein became phosphor-
ylated that was the expected size for GBP (Figure 1C, (Table 1, experiment 1). The higher dose of RNA also
induced more complete axis formation, as evidencedlane 2). When GBP was not ectopically expressed in
embryos, a phosphorylated protein of the same size was by the presence of eyes in the secondary axis. When
GBP RNA was injected on the dorsal side, normal em-coimmunoprecipitated by Xgsk-3-myc, but it was less
abundant than the ectopic GBP (Figure 1C, lane 1). We bryos developed, and axis duplication was never ob-
served (Figure 2A, top embryo; Table 1, experiment 1).hypothesized that this protein could be the endogenous
GBP. To test this, we compared the partial proteolysis Exposure of fertilized eggs to UV radiation prevents
endogenous axis formation that can be rescued by ec-patterns of ectopically expressed GBP and the putative
endogenous GBP using an in-gel proteolysis method topic expression of various dorsalizing factors. We
tested whether ectopic expression of GBP could also(Cleveland et al., 1977). Ectopically expressed GBP and
the putative endogenous GBP have identical V8 prote- rescue axis formation in UV-irradiated embryos. Fertil-
ized eggs were irradiated with UV light and embryosase digestion patterns that are clearly different from the
digestion pattern for a control protein (Figure 1D). This were injected with 0.25 to 2 ng of GBP RNA at the
2- to 4-cell stage, and the results were quantitated byresult was confirmed by digestion with chymotrypsin
Cell
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Table 1. Axis Duplication by GBP and FRAT2
Complete 28 Axis Partial 28 Axis No 28 Axis
Experiment Injections n (%) n (%) n (%)
1 Dorsal 0.5 ng GBP 0 0 27 (100)
Dorsal 1.5 ng GBP 0 0 26 (100)
Ventral 0.5 ng GBP 1 (3) 12 (33) 23 (64)
Ventral 1.5 ng GBP 15 (44) 17 (50) 2 (6)
2 Uninjected 0 0 55 (100)
Ventral Injections
0.25 ng C-GBP 14 (67) 6 (29) 1 (4)
0.5 ng C-GBP 23 (85) 4 (15) 0
1.0 ng C-GBP 31 (97) 1 (3) 0
0.25 ng GBP 0 6 (27) 16 (73)
0.5 ng GBP 0 22 (73) 8 (27)
1.0 ng GBP 3 (10) 21 (70) 6 (20)
3 Uninjected 0 0 45 (100)
Ventral Injections
0.5 ng FRAT2 0 8 (29) 20 (71)
1.0 ng FRAT2 0 23 (79) 6 (21)
2.0 ng FRAT2 9 (28) 23 (72) 0
4 Uninjected 0 0 22 (100)
Ventral Injections
2.0 ng FRAT2 & 1 (3) 23 (74) 7 (23)
4.0 ng Xgsk-3FS
2.0 ng FRAT2 & 0 3 (12) 22 (88)
4.0 ng Xgsk-3
scoring the dorsoanterior index (DAI) of the embryos The Predicted Amino Acid Sequence of Xenopus
GBP and Potential Family Members(Kao and Elinson, 1988), where 5 represents a normal
embryo and 0 indicates an embryo lacking axial struc- We initially could not find any relatives of GBP in the
nucleotide or protein databases and did not find anytures. While UV-irradiated control embryos are severely
ventralized, injection of GBP RNA causes significant axis informative motifs within the GBP protein sequence.
However, two recently entered sequences have pro-rescue (Figure 2B).
If the binding of GBP to endogenous Xgsk-3 inhibits vided important clues to the function of GBP, both in
early development and normal cell growth. Molecularthe function of Xgsk-3, leading to the formation of an
ectopic axis, it should be possible to overcome the cloning of a proviral insertion site identified in T cell
lymphomas experimentally induced by murine retrovi-effects of GBP by ectopically expressing additional
Xgsk-3. Using the UV-rescue assay, we measured the ruses (Sorensen et al., 1996; Jonkers et al., 1997) identi-
fied a protooncogene of unknown function named Frat1effects of GBP on axis formation in the presence or
absence of ectopic Xgsk-3 and found that coinjection of (for frequently rearranged in advanced T cell lympho-
mas). An ortholog of Frat1 was found in humans (FRAT1;RNA encoding Xgsk-3 blocked induction of a secondary
axis (Figure 2C). These results support the contention Jonkers et al., 1997). Both the mouse and human pro-
teins contain three regions that are well-conservedthat GBP functions by binding and inhibiting endoge-
nous Xgsk-3. within GBP (Figure 4A). We found a portion of an addi-
tional human gene, which we designate FRAT2, in the
expressed sequence tag (EST) database. This FRAT2
GBP Regulates the Stability of b-Catenin fragment contains two of the three conserved domains
in Xenopus Embryos shared between Frat1/FRAT1 and GBP (Figure 4A) and
Inhibition of endogenous Xgsk-3, either with a domi- is 59% identical to FRAT1 over the available amino acid
nant-negative mutant or by lithium, results in elevated sequence, indicating that it is a considerably diverged
levels of b-catenin that promotethe formation of a dorsal
axis. To determine whether GBP functions by the same
mechanism, RNA encoding myc epitope±tagged b-cat-
enin (b-catenin-myc; Yost et al., 1996) was injected into
embryos alone or in combination with GBP or dominant-
negative Xgsk-3 RNA, and b-catenin-myc protein levels
were measured by Western blotting with an anti-myc
antibody. When b-catenin-myc was expressed alone,
Figure 3. GBP Stabilizes b-Catenin Levelsvery low levels of the protein accumulated (Figure 3). In
Embryos were injected in two cells at the 4-cell stage with a totalcontrast, when b-catenin-myc was coexpressed with
of 50 pg of b-catenin-myc RNA alone or in combination with 2either GBP or dominant-negative Xgsk-3, high levels of
ng of GBP or dominant-negative Xgsk-3 (dnXgsk-3) RNA. Control
b-catenin-myc protein were detected. This result indi- embryos were uninjected. After 4 hr, b-catenin-myc levels were
cates that, like dominant-negative Xgsk-3, ectopic ex- determined by immunoblotting of protein extracts with anti-myc
antibodies.pression of GBP stabilizes b-catenin in the embryo.
GBP, a GSK-3 Inhibitor
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Figure 4. Amino Acid Alignment of GBP and
the Frat Proteins and Injection Constructs
(A) The amino acid alignment of GBP, mouse
Frat1, human FRAT1, and human FRAT2.
Black boxes depict conserved amino acids,
and gray boxes show similar amino acids.
The three conserved domains are indicated
by roman numerals. A comparison of GBP
and Frat1/FRAT1 shows that domain I is
63% identical, II is 70% identical, and III is
83% identical. The amino acids changed in
GBP(139A140Q) are shown below domain III.
Arrows below the GBP sequence indicate the
positions of the two antisense oligonucleo-
tides used in the antisense depletion experi-
ments.
(B) RNA injection constructs used in this
study with the conserved domains indicated.
The two-hybrid clone is shown for com-
parison.
gene. These results suggest that GBP belongs to a fam- results demonstrate that the axis-inducing and Xgsk-
3±binding activities of the full-length protein are con-ily of vertebrate genes.
tained within the C-terminal region.
The C-Terminal Domain of GBP Binds GSK-3
and Is Sufficient for Axis Duplication Ectopic Expression of FRAT2 Causes
As the clone identified from the yeast two-hybrid screen Axis Duplication
corresponds to the C-terminal half of GBP (Figure 4B), Because the C terminus of GBP contains the GSK-3
this portion of GBP is predicted to contain the GSK- binding and axis-duplicating activity and this region
3±binding domain. To determine whether the conserved shares a conserved domain with FRAT2 (domain III, Fig-
C-terminal domain of GBP was sufficient for binding to ures 4A and 4B), we asked whether FRAT2 could also
GSK-3 in vivo, FLAG epitope±tagged constructs were bind Xgsk-3 and promote axis duplication. Coinjection
made that encode either the carboxyl or amino half of of FRAT2 fused to a FLAG epitope tag with Xgsk-3-myc
GBP, C-GBP and N-GBP, respectively (Figure 4B). RNA demonstrated that it, like GBP, can be immunoprecipi-
synthesized from these constructs was expressed in tated with antibodies to Xgsk-3-myc (data not shown).
Xenopus embryos along with Xgsk-3-myc. The N-termi- Ectopic expression of FRAT2 induced an ectopic axis
nal fragment was not stable in embryos, so we were (Table 1, experiment 3), and coexpression of Xgsk-3
unable to analyze it further (Figure 5, lane 2). However, with FRAT2 blocked its axis-inducing activity (Table 1,
Western analysis revealed that C-GBP coimmunopre- experiment 4). These results demonstrate GBP and the
cipitated GSK-3 as efficiently as the full-length GBP Frat genes constitute a family of GSK-3 inhibitory pro-
(Figure 5, compare lanes 1 and 3). teins.
To test whether C-GBP also was able to inhibit Xgsk-3
function, embryos were injected ventrally with C-GBP
RNA. C-GBP was a potent inducer of a secondary axis, The Axis-Inducing Activity of GBP Requires
GSK-3 Bindingcausing a complete secondary axis in 97% of the em-
bryos (Table 1, experiment 2). The increased activity of The experiments with C-GBP and FRAT2 demonstrate
that the Xgsk-3 binding and axis-duplicating activitiesthe C-terminal fragment relative to full-length GBP is
probably due to the greater level of expression of C-GBP are contained within the C terminus of these proteins,
which share domain III. To determine whether thesein Xenopus embryos (Figure 5, lanes 1 and 3). These
Cell
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139 and 140, which are solvent exposed, with two resi-
dues that are predicted to maintain the integrity of the
helix and thus the overall structure of the protein (By-
stroff and Baker, 1998). To test theactivity of this mutant,
GBP(139A140Q), we compared its binding properties
and axis-inducing activities to those of wild-type GBP.
Western analysis showed that although both wild-type
and mutant GBP proteins were produced at comparable
levels in the embryo (Figure 6A; lanes 2 and 3), GBP
(139A140Q) was not coimmunoprecipitated by Xgsk-3
(Figure 6A; compare lanes 5 and 6) and did not effectively
precipitate Xgsk-3 (Figure 6A; compare lanes 11 and 12).
In the UV axis rescue assay, 1 ng of GBP RNA caused
significant axis rescue, whereas 1 or 2 ng of GBP
(139A140Q) had no effect (Figure 6B). These results dem-
onstrate that the mutation present in GBP(139A140Q)Figure 5. C-GBP Coimmunoprecipitates Xgsk-3
abolishes GSK-3 binding and axis-inducing activity, in-Embryos were injected with 2 ng of RNA encoding either GBP-FLAG
dicating that binding of Xgsk-3 through conserved do-(lane 1), C-GBP-FLAG (lane 2), or N-GBP-FLAG (lane 3) together
with 2 ng of Xgsk-3-myc RNA. Lane 4 is from uninjected embryos. main III is required for the function of GBP and presum-
After 4 hr, proteins were isolated by immunoprecipitation with anti- ably the Frat proteins.
bodies to the FLAG epitope. FLAG-containing proteins were de-
tected by immunoblotting with anti-FLAG antibodies (bottom panel)
and Xgsk-3-myc with anti-myc antibodies (top panel). The positions GBP Inhibits Xgsk-3 Phosphorylation
of Xgsk-3-myc and N-, C-, and GBP-FLAG are marked. Each lane of a Protein Substrate
represents 15 embryos. In this experiment, the FLAG tags were Our work demonstrating that b-catenin is stabilized
placed at the N terminus of all GBP constructs.
when the GSK-3 phosphorylation site is mutated (Yost
et al., 1996) suggests that GBP stabilizes b-catenin by
preventing its phosphorylation by Xgsk-3. An excellentamino acids constitute the critical region for GBP activ-
ity, we sought to mutate GBP in this region without in vivo GSK-3 assay has recently been developed by
Klein and colleagues (Hedgepeth et al., 1997). This assayperturbing the overall structure of the protein. Based on
structure prediction analysis of GBP, domain III forms takes advantage of the observation that the microtu-
bule-binding protein, tau, is a GSK-3 substrate (Hangeran a helix. We replaced the amino acids at positions
Figure 6. The Point Mutant GBP(139A140Q)
Lacks Xgsk-3±Binding and Axis-Inducing Ac-
tivity
(A) Embryos were injected in the marginal
zone at the 2- to 8-cell stage with 2 ng of
RNA encoding GBP(139A140Q)-FLAG or GBP-
FLAG with or without 2 ng of Xgsk-3-myc
RNA, as indicated. After 4 hr, proteins were
isolated by immunoprecipitation with anti-
bodies to the myc or FLAG epitope, as indi-
cated, and run on a 10% polyacrylamide gel.
Xgsk-3-myc and the FLAG-tagged proteins
were detected by immunoblotting with anti-
FLAG (left side) and anti-myc (right side) anti-
bodies.
(B) Fertilized eggs were UV-irradiated and in-
jected with GBP or GBP(139A140Q) RNA at
the doses indicated, and the DAI was scored
at 3 days. UV control embryos were unin-
jected.
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Xgsk-3, as shown with the antibody specific for GSK-3
phosphorylated tau (Figure 7B; lanes 1 and 5). Coinjec-
tion of GBP eliminated the highest molecular weight
forms of tau (Figure 7A, lane 2) and reduced the level
of GSK-3±specific phosphorylation 5-fold (Figure 7B,
lane 2; Figure 7C), whereas the GBP mutant had no effect,
either on the mobility or GSK-3±specific phosphoryla-
tion of tau (Figures 7A and 7B, lane 3; Figure 7C). These
results demonstrate that GBP functions to inhibit the
ability of Xgsk-3 to phosphorylate protein substrates
and that this inhibition requires binding to Xgsk-3.
GBP Is Required for Dorsal-Ventral Axis
Formation in Xenopus
To determine whether GBP is required for normal Xeno-
pus development, we depleted the maternal GBP RNA
using the procedure of Heasman and coworkers (1991).
We tested 11 oligodeoxynucleotides that spanned the
GBP coding region and found two adjacent oligonucleo-
tides, as34 and as35 (Figure 4A), that effectively de-
creased the level of the GBP mRNA, with higher doses
producing a stronger effect (data not shown). We found
that injection of 6 ng of as34 per oocyte, which is well
below the recommended maximum of 10 ng (J. Heas-
man, personal communication), depleted GBP mRNA
(Figure 8A, compare lanes 1 and 3), whereas a control
oligonucleotide had no effect (Figure 8A, lane 2).
Oocytes were injected with as34 or a control oligonu-
cleotide and implanted into host mothers, along with
uninjected oocytes, after the oocytes were matured inFigure 7. tau Phosphorylation by Xgsk-3 Is Blocked by GBP
vitro. Both the uninjected (n 5 76) and control-injected
Oocytes were injected with 1 ng of RNA encoding GSK-3-myc to-
(n 5 31; Figure 8B) embryos from these experimentsgether with 10 ng of either a control RNA (Xgsk-3FS; lane 1), wild-
developed normally, whereas the as34-injected oocytestype GBP-FLAG RNA (lane 2), or GBP(139A140Q)-FLAG RNA (lane
3). Following an overnight incubation, the oocytes were injected were ventralized (n 5 83; Figure 8B). To measure the
with 10 ng of recombinant tau protein. Two hours after tau injection, extent of ventralization, the dorso-anterior index (DAI)
extracts from oocytes were analyzed by Western blotting. Lane 4 was used. Whereas 90% of the uninjected and control-
is from uninjected oocytes and lane 5 from oocytes injected with
injected oocytes were normal (Figures 8C and 8D), as34-tau alone. (A) Total tau protein was detected using a combination
injected oocytes showed a full range of ventralized phe-of anti-T14 and T46 antibodies. (B) Anti-PHF1 antibodies were used
notypes (Figures 8B and 8E). To ensure the effects weto detect tau phosphorylated by GSK-3. (C) The samples in (A) and
(B) werequantified by densitometry and the levels of phosphorylated observed were specific for GBP, we also examined oo-
tau protein are depicted as a fraction of the total tau in (A). In two cytes injected with as35 and observed a similar range
other experiments tau phosphorylation was reduced 3- and 7-fold of phenotypes to that seen with as34 (data not shown).
in the presence of wild-type GBP.
These results demonstrate that maternal GBP RNA is
required for the normal formation of the dorsal-ventral
axis in Xenopus.et al., 1992; Mandelkow et al., 1992), and antibodies
specific for the GSK-3±phosphorylated form of tau are
available (Greenburg et al., 1992; Otvos et al., 1994). Discussion
To measure Xgsk-3 activity, oocytes were injected
with Xgsk-3-myc RNA together with either a control RNA To account for the localized stabilization of b-catenin
in early Xenopus embryos, we previously proposed that(Xgsk-3FS), wild-type GBP-FLAG RNA, or RNA encoding
the GBP mutant, GBP(139A140Q)-FLAG. Following an Xgsk-3 is inhibited within the future dorsal region during
the early cleavage stages (Pierce and Kimelman, 1995;overnight incubation, the oocytes were injected with
recombinant tau protein, and 2 hr later, extracts from Moon and Kimelman, 1998). While GSK-3 can be inhib-
ited by phosphorylation at a specific amino-terminal ser-oocytes were analyzed by Western blotting using either
anti-tau antibodies T14/46 (Kosik et al., 1988) that recog- ine residue in several signaling pathways (reviewed in
Yost et al., 1997), our studies with a mutant lackingnize all forms of tau (Figure 7A) or an antibody specific
for the GSK-3 phosphorylated form of tau (Figure 7B; this serine suggested that Xgsk-3 is regulated by an
alternative mechanism in the early Xenopus embryoGreenburg et al., 1992; Otvos et al., 1994). In the pres-
ence of Xgsk-3, tau migrated as a series of higher molec- (S. B. P. and D. K., unpublished results). These results,
combined with other experiments indicating that theular weight forms that were absent when Xgsk-3 was
not present (Figure 7A; compare lanes 1 and 5). The normal Wnt signaling pathway is not used to specify the
initial steps of axis formation (Hoppler et al., 1996; Sokol,slower migrating forms are due to phosphorylation by
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Figure 8. GBP Depletion CausesVentralization
Stage VI oocytes were either left uninjected
or injected with 6 ng of control or as34 oligo-
nucleotides, matured in vitro, and trans-
planted into host mothers. To verify GBP RNA
depletion, RNA from 10 oocytes was pooled
and used in an RNase protection assay (A) in
which GBP and Ef1-a were used as probes.
(B) Representative embryos from control oli-
gonucleotide injected (top embryo) or as34-
injected (bottom six embryos) oocytes. Em-
bryos from two experiments were assigned
DAI scores, and the percentage of embryos
at each DAI was graphed. (C) Uninjected oo-
cytes, n 5 76; (D) control oligonucleotide, n 5
31; (E) as34, n 5 83.
1996), led us to search for an alternative mechanism of the identification of GBP from two-hybrid studies sup-
ports the model that GBP directly binds GSK-3, it isGSK-3 regulation. We have identified here an essential
maternal protein that binds Xgsk-3 and inhibits its func- possible that this interaction is mediated by a linker
protein. We are currently developing the tools to distin-tion inXenopus embryos.GBP is nowthe most upstream
member of the maternal Wnt pathway that has been guish between these possibilities.
shown to be required for axis formation in Xenopus.
GBP Inhibits Phosphorylation by Xgsk-3
To test whether GBP functions by inhibiting the ability ofGBP Belongs to a Family of GSK-3±Binding Proteins
Xgsk-3 to phosphorylate substrates, we used a recentlyTwo recently identified proteins, Frat1/FRAT1 and FRAT2
developed in vivo assay that measures the GSK-3±(Jonkers et al., 1997; our results), have provided impor-
dependent phosphorylation of tau protein in Xenopustant insight into the structure and function of GBP. The
oocytes (Hedgepeth et al., 1997). tau is a natural GSK-3Frat proteins share three well-conserved regions with
substrate for which antibodies have been made thatGBP that we predict are important for the activity and
specifically recognize the GSK-3±phosphorylated form.regulation of the Frats and GBP. Our studies demon-
The tau assay has been used to demonstrate that lithiumstrate that region III, which is the most highly conserved
inhibits the kinase activity of Xgsk-3 (Hedgepeth et al.,domain, contains the GSK-3 binding and inhibitory activ-
1997), and we have shown the same results with GBP.ities. A C-terminal fragment of GBP, which lacks do-
We found on average a 5-fold reduction in Xgsk-3 activ-mains I and II, binds Xgsk-3 and induces an ectopic
ity in the presence of wild-type versus mutant GBP inaxis, and replacement of two adjacent residues in region
multiple experiments. These observations support aIII abrogates both Xgsk-3 binding and axis induction.
mechanism in which GBP binding to Xgsk-3 preventsImportantly, a fragment of FRAT2 containing domains
substrate phosphorylation.II and III binds Xgsk-3 in vivo and induces an ectopic
axis, demonstrating that FRAT2 and GBP share the
same function, which is most likely due to the conserved GBP and Dorsal-Ventral Axis Establishment
in Xenopusamino acids in domain III. While we have not tested the
activity or GSK-3 binding ability of FRAT1, which is much With the emerging understanding of the role of the Wnt
pathway in Xenopus development (reviewed in Mooncloser in sequence to FRAT2 than is GBP, we propose
that all of these proteins form a family of GSK-3±binding and Kimelman, 1998), we can suggest how GBP func-
tions in regulating axis formation. When bound to axin,proteins that interact with GSK-3 via domain III. Although
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Experimental ProceduresXgsk-3 phosphorylates b-catenin (Peifer et al., 1994a;
Yost et al., 1996; Ikeda et al., 1998), leading to the degra-
Isolation of GBP cDNAsdation of b-catenin by the ubiquitin-proteasome path- A two-hybrid library was constructed essentially as described (Hol-
way (Aberle et al., 1997). We propose that GBP functions lenberg et al., 1995) from oocyte and egg poly(A)1 RNA and 5 3
to locally inhibit Xgsk-3, leading to an elevation in 106 library transformants were screened with a Xgsk-3-LexA bait
plasmid (MM-XGSK3; details upon request) as described (Hollen-b-catenin levels on the future dorsal side of the embryo,
berg et al., 1995). Histidine-positive colonies were assayed forwhich results in the activation of siamois and theultimate
b-galactosidase activity using a filter assay (Durfee et al., 1993).formation of the body axes (Moon and Kimelman, 1998).
Thirteen clones containing the same 274 bp insert were isolated
Our finding that the Xenopus embryo expresses a and used to screen a Xenopus oocyte cDNA library (Rebagliati et
maternal cytoplasmic GSK-3 inhibitory protein suggests al., 1985). Sequence analysis of the 6 cDNAs isolated revealed that
a mechanism by which Xgsk-3 can be inhibited without the GBP transcript is approximately 4 kb.
involving the upstream members of the Wnt pathway.
RNA Expression VectorsThe early cortical rotation has been proposed to move
C-terminal myc epitope-tagged wild-type (XG134) and dominant-an activator of the Wnt pathway from the vegetal pole
negative (XG137) forms of Xgsk-3 were generated using PCR and
to the dorsal region of the embryo (reviewed in Moon introduced between the BamH1 and Cla1 sites of CS21MT (Turner
and Kimelman, 1998). GBP might be this factor, or it and Weintraub, 1994). Frameshift GSK-3 (XG92) was previously de-
may be regulated posttranslationally by a translocated scribed (Pierce and Kimelman, 1995). A GBP expression vector
(GSKBP-1-CS) was produced by inserting the GBP coding regionfactor through conserved domains I and II. While we
into CS21 (Turner and Weintraub, 1994). N-terminal FLAG epitope-have shown that GBP can inhibit Xgsk-3 by ectopically
tagged forms of full-length GBP (BP22), the N- (BP23) and C- (BP24)expressing only domain III, the activation of the other
terminal halves of GBP, and a C-terminal FLAG form of full-length
domains through a posttranslational mechanism could GBP (BP20) were produced by PCR (details upon request). A mutant
greatly enhance the affinity of GBP for Xgsk-3, which form of GBP with (BP139) or without a FLAG tag (BP139-CS) was
constructed by oligonucleotide-mediated site-directed mutagene-may be critical at the GBP levels that are normally pres-
sis (Kunkel et al., 1987) to mutate residues 139 and 140 of GBPent in the embryo. These other domains could also be
(139K.A and 140E.Q), using the oligonucleotide 5-CGGGAAACCTimportant for the regulation of the mammalian members
CATTGCGCAGGCGGTCAGGA-39. All RNAwas synthesized from the
of this family (see below). It is also possible that GBP CS21 derived vectors, linearized with either Asp718 or NotI, using
is a novel member of the intracellular pathway through the SP6 mMESSAGE mMACHINE kit (Ambion) as described (Yost
which Wnt stabilizes b-catenin and is not part of an et al., 1996).
alternate pathway. In this view, the cortical activity
RNA Isolation and RNase Protectionwould regulate GBP posttranslationally, using the same
Total RNA was prepared using Tri-Reagent (Molecular Researchmechanism as Wnt signaling.
Center, Cincinnati, Ohio) and analyzed with the RNase protection
assay (Melton et al., 1984). Antisenseprobe was generated by linear-
izing pBPCSK, which contains the 39 half of the GBP coding region
A Role for the GBP/Frat Family in pBluescriptII SK1 (Stratagene), with BamHI and transcribing with
T7 RNA polymerase. For Figure 1, duplicate RNA samples werein Cell Proliferation
hybridized with a Xenopus FGF receptor probe (Musci et al., 1990).Understanding thenormal cellular functions of key regu-
Probes were hybridized with 12 mg of RNA. For Figure 8, an Ef1-alatory proteins is critical for the study of cancer, in which
probe was used as described (Cornell and Kimelman, 1994). For
growth control mechanisms are impaired or have been each sample, RNA was isolated from ten matured oocytes at the
bypassed. Lacking the restraints present in normal cells, time when siblings were implanted into host females. One-third of
the RNA was then used in a single RNase protection reaction. Alla number of components of signal transduction path-
samples were treated with 200 U/ml RNase T1 (Sigma) for 1 hr atways have been identified as protooncogenes. Frat1
room temperature.was identified in a screen designed to identify cooper-
ating oncogenes responsible for accelerating late-stage
Embryos and Oocytes
tumor development in mice that produce a high level Fertilized embryos were obtained as previously described (Newport
of T cell lymphomas due to the presence of another and Kirschner, 1982). Ovaries were surgically removed from female
frogs and the oocytes defolliculated manually. Oligonucleotideoncogene (Jonkers et al., 1997). Our studies with GBP
depletion of maternal mRNA was performed as previously describedprovide a basis for understanding the proliferation of
(Heasman et al., 1991). Six nanograms of either as34 (59-CCCCATCClymphoma cells overexpressing Frat1. Because Frat1
CCTGCCGCAC-39) or control oligo (59-CGGCTCCCGTTCCCGCAC-
contains the conserved domain III, it is likely to bind 39) was injected into stage VI oocytes.
and inhibit GSK-3, and we predict that it stimulates T
cell lymphoma proliferation by decreasing GSK-3 func- Immunoprecipitation, Western Blotting, and Kinase Labeling
For immunoprecipitations, embryos were lysed in Triton X-100 lysistion. In support of this, GSK-3 has been shown to act
buffer (Rubinfeld et al., 1993) without Pefabloc, and half of the clearas a negative regulator of NF-ATc (nuclear factor acti-
supernatant was retained after centrifugation. Proteins were immu-vated in T cells; Beals et al., 1997), which is a direct
noprecipitated at 48C with mouse anti-myc monoclonal (Oncogene
activator of the T cell±specific cytokine IL-2 gene ex- Science) or rabbit anti-FLAG polyclonal antibody (Santa Cruz Bio-
pression (Rooney et al., 1995). We suggest that inhibition technology) and protein G-Sepharose beads (Sigma). For detection
by Western blotting or kinase labeling, the beads were washed withof GSK-3 by Frat1 in the lymphoma cells overexpressing
buffer B (Rubinfeld et al., 1993) and boiled in SDS-PAGE sampleFrat1 causes NF-AT to induce IL-2 production, enhanc-
buffer or labeled with 32P using protein kinase A (Boehringer Mann-ing proliferation. In support of this, lithium, which inhibits
heim; Zeng et al., 1996). Proteins were detected using the above
GSK-3, has been shown to enhance the production of primary antibodies followed by the appropriate horseradish peroxi-
IL-2 (Kucharz et al., 1988; Wu and Yang, 1991) and cause dase-conjugated secondary antibody (Zymed), and blots were de-
veloped using enhanced chemiluminescence (Amersham).T cell proliferation (Kucharz et al., 1988).
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GSK-3 tau Kinase Assay Durfee, T., Becherer, K., Chen, P., Yeh, S., Yang, Y., Kilburn, A.E.,
Lee, W., and Elledge, S.J. (1993). The retinoblastoma protein associ-The tau asssay was performed essentially as described (Hedgepeth
ates with the protein phosphatase type 1 catalytic subunit. Geneset al., 1997). In our experiments oocytes were manually defollicu-
Dev. 7, 555±569.lated and injected with 10 ng of either BP20, XG92, or BP139 RNA
together with 1 ng of XG134 RNA. Total and phosphorylated tau Fagotto, F., Guger, K., and Gumbiner, B.M. (1997). Induction of the
protein was detected using anti-T14/46 (a gift from V. M.-Y. Lee; primary dorsalizing center in Xenopus by the Wnt/GSK/b-catenin
Kosik et al., 1988; Hong and Lee, 1997) and anti-PHF1 antibodies signaling pathway, but not Vg1, Activin or Noggin. Development
(a gift from P. Davies; Greenburg et al., 1992), respectively. 124, 453±460.
Fan, M.J., and Sokol, S.Y. (1997). A role for siamois in Spemann
In-Gel Protease Mapping organizer formation. Development 124, 2581±2589.
In-gel protease mapping was performed by a modification of the Gerhart, J.C., Stewart, R., and Doniach, T. (1991). Organizing the
published procedure (Cleveland et al., 1977). Buffers were as de- Xenopus organizer. In Gastrulation: Movements, Patterns, and Mol-
scribed, with the addition of 2.5 mM DTT, and the protease dilution ecules, R. Keller, W. Clark, Jr., and F. Griffin, eds. (New York, Ple-
buffer included 0.1% bromophenol blue. Proteins in wet unfixed gel num), pp. 57±77.
slices were digested with 1 mg Staphylococcus aureus V8 protease
Greenburg, S.G., Davies, P., and Binder, L.I. (1992). Hydrofluoric(Sigma).
acid-treated tau-PHF proteins display the same biochemical proper-
ties as normal tau. J. Biol. Chem. 267, 564±569.
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